Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Great jog

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Dec 07, 2021 2:27pm

136 Views

Post# 34207386

RE:RE:Great jog

talisman47 wrote: my guess is they will keep pushing the stock lower until they are ready to load themselves up wit new stock, options, warrants, etc.. Somebody might invest money in return for stock, etc. Right now there are only approx. 2M shares. They need to keep some stories alive while they reload for themselves to make money in the future selling us on big ideas.......same old, pump/flush routine

Yes, our depleted to 5 cent shares are now worth 3.8 cents. Is anybody(common small retail shareholder) chasing good money after bad to reload the tiny holding you ended up with?

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale